Global Biomaterials Market Insights, Size and Growth Forecast To 2027

COVID-19
Global Biomaterials Market by Type (Metallic, Ceramic, Polymeric, and Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology and Others) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa) Global Forecast to 2027
Request COVID-19
impact analysis

Global Biomaterials Market by Type (Metallic, Ceramic, Polymeric, and Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology and Others) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa) Global Forecast to 2027

Published: Dec 2020 Base Year: 2019 Report ID: HLCA2047
Available Format: Historical Data: 2017 - 2018 Number of Pages: 1 - 250
Category : Health Care
Global Biomaterials market likely to drive by the rising demand to support damaged biological structure specifically in cardiovascular, orthopaedic and cochlear among others. Global Biomaterials market projected to grow with a remarkable rate during the forecast period, 2020-2027. It is due to the rise in the geriatric population, surge in production of implantable products, and advancements in medical technology. Moreover, the upsurge in demand for smart biomaterials that produce and transfer bioelectric signals similar to native tissues for accurate physiological functions are estimated to trigger the global biomaterials market in the upcoming years. Additionally, the financial aids by government bodies in emerging countries for the development of novel biomaterials will promulgate the global biomaterials market size. Increasing the prevalence of musculoskeletal and chronic skeletal medical conditions is augmenting the demand for biomaterial-based implants.
The aging process of the population and human pursuit of health and longevity have stimulated the demand for biomaterials. According to WHO, by 2050, the world's population aged 60 years and older is expected to reach to total 2 billion, up from 900 million in 2015. WHO also states that by 2020, the number of people aged 60 years and older will outnumber children younger than five years. Furthermore, the geriatric population is susceptible to acquire orthopaedic and cardiovascular diseases easily as a result of their low immune system, which influences the growth of the biomaterial industry in the forecast periods. In the Asia-Pacific, cancer is one of the leading causes of death; in Western countries, the number one killer is cardiovascular disease. With the improvement of people's quality of life, plastic surgery, and beauty are emerging, the demand for biomedical materials in family planning is growing.
In addition, the high prevalence of cardiac disorders, increasing orthopaedic procedures, dental surgeries, and cardiovascular surgeries are projected to fuel the global biomedical materials industry in the next few years.

Product Type Overview in the Global Biomaterials Market
Based on product type, the global Biomaterials Market classified into Metallic, Ceramic, Polymeric, and Natural. The Metallic segment anticipated to generate maximum market revenue by 2027, attributable to metallic biomaterials used in the joint replacements, dental implants, orthopaedic fixations, and stents.
The polymeric segment will be the fastest-growing segment on account of the rising usage of polymer biomaterials in soft tissue applications, including plastic surgeries.
The natural segment will influence owing to their naturally derived biomaterials that are usually applied to restore or replace the structure and function of damaged tissues/organs.

Application Overview in the Global Biomaterials Market
Based on application, the global Biomaterials Market classified into Cardiovascular, Orthopaedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology, and Others. The Cardiovascular segment witnessed a higher growth in 2019. It is projected to lead the market by 2027 due to a number of diagnostic and therapeutic biomaterials devices that have developed for cardiac applications such as catheters, guidewires, sensors, pacemakers, implantable cardioverter defibrillators, vascular grafts, heart valves, and stents. 
The orthopaedic segment will be the fastest-growing segment on account of repairing different tissues such as cartilage, bone, ligaments, and tendons for the various bone-related problems such as fracture, scoliosis, osteoporosis, and lower.
The plastic surgery segment will grow by the rise in the number of cosmetic procedures and increased usage of biomaterials in these surgeries.

Regional Overview in the Global Biomaterials Market
By geography, the Global Biomaterials Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. The Asia-Pacific region will be the fastest-growing segment owing to the rising prevalence of cardiovascular diseases coupled with huge demand for tissue engineering and plastic surgery. Additionally, the government and private initiatives have surged awareness regarding biomaterial application will boost the Asia-Pacific biomaterials market. 

Global Biomaterials Market: Competitive Landscape
Companies such as Royal DSM, BASF SE, Corbion, Carpenter Technology Corporation, Evonik Industries, Berkeley Advanced Biomaterials, Cam Bioceramics B.V., Celanese Corporation, CoorsTek Inc. CeramTec, Medtronic plc, Invibio Ltd., Zimmer Biomet Holdings, Inc., and GELITA AG are the key players in the Global Biomaterials Market. 


1. Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation

2. Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition 
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation 

3. Executive Summary

4. Market Insights
4.1. Economic Factor Analysis 
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Technological Landscape
4.3. Competitors & Product Analysis
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porter’s Five forces analysis
4.7. New Investment Analysis
4.8. PESTEL Analysis

5. Global Biomaterials Market Overview
5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Type
5.2.1.1. Metallic
5.2.1.2. Ceramic
5.2.1.3. Polymeric
5.2.1.4. Natural
5.2.2. By Application 
5.2.2.1. Cardiovascular
5.2.2.2. Orthopedic
5.2.2.3. Dental
5.2.2.4. Plastic Surgery
5.2.2.5. Wound Healing
5.2.2.6. Neurological disorders
5.2.2.7. Tissue Engineering
5.2.2.8. Ophthalmology
5.2.3. By Region
5.2.3.1. North America
5.2.3.2. Europe
5.2.3.3. Asia Pacific
5.2.3.4. South America 
5.2.3.5. Middle East & Africa 

6. North America Biomaterials Market Overview
6.1. North America Biomaterials Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. North America Biomaterials Market Share & Forecast, 2016-2027
6.2.1. By Type
6.2.1.1. Metallic
6.2.1.2. Ceramic
6.2.1.3. Polymeric
6.2.1.4. Natural
6.2.2. By Application 
6.2.2.1. Cardiovascular
6.2.2.2. Orthopedic
6.2.2.3. Dental
6.2.2.4. Plastic Surgery
6.2.2.5. Wound Healing
6.2.2.6. Neurological disorders
6.2.2.7. Tissue Engineering
6.2.2.8. Ophthalmology
6.2.3. By Country
6.2.3.1. US
6.2.3.2. Canada
6.2.3.3. Mexico
6.2.4. Company Market Share (Top 3-5)
6.2.5. Economic Impact Study on North America Biomaterials Market 

7. Europe Biomaterials Market Overview
7.1. Europe Biomaterials Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Europe Biomaterials Market Share & Forecast, 2016-2027
7.2.1. By Type
7.2.1.1. Metallic
7.2.1.2. Ceramic
7.2.1.3. Polymeric
7.2.1.4. Natural
7.2.2. By Application 
7.2.2.1. Cardiovascular
7.2.2.2. Orthopedic
7.2.2.3. Dental
7.2.2.4. Plastic Surgery
7.2.2.5. Wound Healing
7.2.2.6. Neurological disorders
7.2.2.7. Tissue Engineering
7.2.2.8. Ophthalmology
7.2.3. By Country
7.2.3.1. Germany
7.2.3.2. UK
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Rest of Europe
7.2.4. Company Market Share (Top 3-5)
7.2.5. Economic Impact Study on Europe Biomaterials Market 

8. Asia Pacific Biomaterials Market Overview
8.1. Asia Pacific Biomaterials Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific Biomaterials Market Share & Forecast, 2016-2027
8.2.1. By Type
8.2.1.1. Metallic
8.2.1.2. Ceramic
8.2.1.3. Polymeric
8.2.1.4. Natural
8.2.2. By Application 
8.2.2.1. Cardiovascular
8.2.2.2. Orthopedic
8.2.2.3. Dental
8.2.2.4. Plastic Surgery
8.2.2.5. Wound Healing
8.2.2.6. Neurological disorders
8.2.2.7. Tissue Engineering
8.2.2.8. Ophthalmology
8.2.3. By Country
8.2.3.1. China
8.2.3.2. India
8.2.3.3. Japan
8.2.3.4. Australia
8.2.3.5. Rest of Asia Pacific
8.2.4. Company Market Share (Top 3-5)
8.2.5. Economic Impact Study on Asia Pacific Biomaterials Market 

9. South America Biomaterials Market Overview
9.1. South America Biomaterials Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America Biomaterials Market Share & Forecast, 2016-2027
9.2.1. By Type
9.2.1.1. Metallic
9.2.1.2. Ceramic
9.2.1.3. Polymeric
9.2.1.4. Natural
9.2.2. By Application 
9.2.2.1. Cardiovascular
9.2.2.2. Orthopedic
9.2.2.3. Dental
9.2.2.4. Plastic Surgery
9.2.2.5. Wound Healing
9.2.2.6. Neurological disorders
9.2.2.7. Tissue Engineering
9.2.2.8. Ophthalmology
9.2.3. By Country
9.2.3.1. Brazil
9.2.3.2. Argentina
9.2.3.3. Rest of South America
9.2.4. Company Market Share (Top 3-5)
9.2.5. Economic Impact Study on South America Biomaterials Market

10. Middle East & Africa Biomaterials Market Overview
10.1. Middle East & Africa Biomaterials Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa Biomaterials Market Share & Forecast, 2016-2027
10.2.1. By Type
10.2.1.1. Metallic
10.2.1.2. Ceramic
10.2.1.3. Polymeric
10.2.1.4. Natural
10.2.2. By Application 
10.2.2.1. Cardiovascular
10.2.2.2. Orthopedic
10.2.2.3. Dental
10.2.2.4. Plastic Surgery
10.2.2.5. Wound Healing
10.2.2.6. Neurological disorders
10.2.2.7. Tissue Engineering
10.2.2.8. Ophthalmology
10.2.3. By Country
10.2.3.1. Saudi Arabia
10.2.3.2. UAE
10.2.3.3. South Africa
10.2.3.4. Rest of Middle East & Africa
10.2.4. Company Market Share (Top 3-5)
10.2.5. Economic Impact Study on Middle East & Africa Biomaterials Market

11. Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel 
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Royal DSM
11.7.2. BASF SE
11.7.3. Corbion
11.7.4. Carpenter Technology Corporation
11.7.5. Evonik Industries
11.7.6. Berkeley Advanced Biomaterials
11.7.7. Cam Bioceramics B.V.
11.7.8. Celanese Corporation
11.7.9. CoorsTek Inc.
11.7.10. CeramTec
11.7.11. Medtronic plc
11.7.12. Invibio Ltd.
11.7.13. Zimmer Biomet Holdings, Inc.
11.7.14. GELITA AG
11.7.15. Other Prominent Players


SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 3400
  • 20% off
             
    $ 4700
  • 25% off
         
    $ 6400
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us